SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hermine Brunner, Kathleen Graham Lomax, Stephane Levy, Half-Life and Safety of Canakinumab in Pediatric Patients: Comment on the Article by Ilowite et al, Arthritis & Rheumatology, 2015, 67, 3
  2. 2
    Julie Autmizguine, Michael Cohen-Wolkowiez, Norman Ilowite, for the RAPPORT investigators, Rilonacept pharmacokinetics in children with systemic juvenile idiopathic arthritis, The Journal of Clinical Pharmacology, 2015, 55, 1
  3. 3
    Takashi Satoh, Atsushi Otsuka, Emmanuel Contassot, Lars E French, The inflammasome and IL-1β: implications for the treatment of inflammatory diseases, Immunotherapy, 2015, 7, 3, 243

    CrossRef

  4. 4
    Alexei A Grom, Canakinumab for the treatment of systemic juvenile idiopathic arthritis, Expert Review of Clinical Immunology, 2014, 10, 11, 1427

    CrossRef